Home
/
Prime Medicine, Inc.
/
Financials
/
Quarterly
Prime Medicine, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Prime Medicine, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.23M
Nov 7, 2025
Q2
2025
Jun 30, 2025
$1.12M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$1.45M
May 8, 2025
Q3
2025
Sep 30, 2024
$209.0K
Nov 7, 2025
Q2
2025
Jun 30, 2024
$0
Aug 7, 2025
Q1
2025
Mar 31, 2024
$591.0K
May 8, 2025
Q3
2024
Sep 30, 2023
$0
Nov 12, 2024
Q2
2024
Jun 30, 2023
$0
Aug 8, 2024
Q1
2024
Mar 31, 2023
$0
May 10, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($50.58M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($52.59M)
Aug 7, 2025
Q3
2025
Jun 30, 2025
($52.59M)
Nov 7, 2025
Q3
2025
Mar 31, 2025
($51.89M)
Nov 7, 2025
Q1
2025
Mar 31, 2025
($51.89M)
May 8, 2025
Q2
2025
Mar 31, 2025
($51.89M)
Aug 7, 2025
Q3
2025
Sep 30, 2024
($52.52M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($55.33M)
Aug 7, 2025
Q3
2025
Jun 30, 2024
($55.33M)
Nov 7, 2025
Q1
2025
Mar 31, 2024
($45.76M)
May 8, 2025
Q3
2025
Mar 31, 2024
($45.76M)
Nov 7, 2025
Q2
2025
Mar 31, 2024
($45.76M)
Aug 7, 2025
Q3
2024
Sep 30, 2023
($50.71M)
Nov 12, 2024
Q3
2024
Jun 30, 2023
($42.39M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($42.39M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($39.40M)
May 10, 2024
Q2
2024
Mar 31, 2023
($39.40M)
Aug 8, 2024
Q3
2024
Mar 31, 2023
($39.40M)
Nov 12, 2024
Q3
2023
Sep 30, 2022
($29.35M)
Nov 3, 2023
Q3
2023
Jun 30, 2022
($29.35M)
Nov 3, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($53.97M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($53.38M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($52.39M)
May 8, 2025
Q3
2025
Sep 30, 2024
($54.23M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($55.67M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($48.34M)
May 8, 2025
Q3
2024
Sep 30, 2023
($51.46M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($45.26M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($40.03M)
May 10, 2024
Q3
2023
Sep 30, 2022
($31.66M)
Nov 3, 2023
Q2
2023
Jun 30, 2022
($26.31M)
Aug 7, 2023
Q1
2023
Mar 31, 2022
($19.90M)
May 11, 2023
Q3
2022
Sep 30, 2021
($10.43M)
Nov 14, 2022